Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Usefulness of Preoperative Levels of Leukocyte and D-Dimer in Predicting Perioperative Outcomes of Cardiovascular Disease

심혈관질환의 수술기주위 결과예측에 있어 수술 전 백혈구 수 및 D-dimer 농도의 임상적 유용성

  • Choi, Seok-Cheol (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Kim, Yang-Weon (Department of Emergency Medicine, Inje University Busan Paik Hospital) ;
  • Hwang, Soo-Myung (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan)
  • 최석철 (부산가톨릭대학교 보건과학대학 임상병리학과) ;
  • 김양원 (인제대학교의과대학 부산백병원 응급의학과) ;
  • 황수명 (부산가톨릭대학교 보건과학대학 임상병리학과)
  • Received : 2010.08.09
  • Accepted : 2010.10.12
  • Published : 2010.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

The present study was retrospectively designed to define whether preoperative levels of leukocytes and D-dimer are potentially useful factors in predicting perioperative outcomes of coronary heart disease (CHD). There was no relationship between preoperative leukocyte counts (Pre-OP leukocyte) and preoperative D-dimer levels (Pre-OP D-dimer). Pre-OP leukocyte counts each had positive correlation with cardiac troponin-I, creatine kinase-MB or C-reactive protein (cardiac markers) levels at preoperative and postoperative periods. Pre-OP D-dimer levels were positively associated with each cardiac marker at the same periods. Pre-OP leukocyte counts positively related with aspartate aminotransferase and alanine aminotransferase (liver markers), whereas Pre-OP D-dimer level positively or negatively correlated with bilirubin (liver marker), creatinine (renal marker) or glucose levels at preoperative and/or postoperative periods. Pre-OP leukocyte and Pre-OP D-dimer were inversely associated with Pre-OP high density lipoprotein cholesterol levels or left ventricular ejection fraction. Pre-OP leukocyte counts each had positive correlation operation duration and postoperative mechanical ventilation-time (PMVT), whereas Pre-OP D-dimer levels had positive relationship with PMVT, intensive care unit-staying period and hospitalization. The retrospective data suggest that Pre-OP leukocyte and Pre-OP D-dimer levels may be clinically useful factors for predicting perioperative outcomes in patients with CHD.

이 연구는 관상동맥질환 수술기주위의 결과예측에 있어 수술 전 백혈구 및 D-dimer 수치가 유용한 인자가 될 수 있는지를 규명하기 위해 회고적으로 실시하였다. 수술 전 백혈구 수는 수술 전 및 후의 심장표지자인 troponin-I, creatine kinase-MB, C-반응단백 각각의 농도와 정의 상관성이 있었다. 수술 전 D-dimer 농도 역시 수술기주위의 심장표지자들과 정의 상관관계를 보였다. 수술 전 백혈구 수는 간표지자인 aspartate aminotransferase 및 alanine aminotransferase의 수술 전후 농도와 정의 상관관계를 보였는데 비해, 수술 전 D-dimer 농도는 수술 전후 빌리루빈 농도, 수술 전 글루코스 농도, 수술 후 크레아티닌 농도와 각각 정 또는 역의 상관관계가 있었다. 수술 전 백혈구 및 D-dimer 수치 둘 다 수술 전 고밀도콜레스테롤 농도 및 좌심실구출계수와 각각 역의 상관관계가 있었다. 수술전 백혈구 수는 수술시간 및 수술 후 기계보조 호흡시간과 각 정의 상관관계를 보였고, 수술 전 D-dimer 농도는 수술 후 기계보조 호흡시간, 중환자실 치료기간, 재원기간과 각 정의 상관관계가 있었다. 이 회고적 조사의 결과는 수술 전 백혈구 및 D-dimer 수치가 관상동맥수술 환자들의 수술기주위 결과예측에 있어 임상적으로 유용한 인자들이 될 수 있음을 시사하고 있다.

Keywords

References

  1. Alpert, J. S., K. Thygesen, E. Antman, and J. P. Bassand. 2000. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36, 959-969. https://doi.org/10.1016/S0735-1097(00)00804-4
  2. Calabro, P., J. T. Willerson, and E. T. Yeh. 2003. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108, 1930-1932. https://doi.org/10.1161/01.CIR.0000096055.62724.C5
  3. Carobbio, A., G. Finazzi, V. Guerini, O. Spinelli, F. Delaini, R. Marchioli, G. Borrelli, A. Rambaldi, and T. Barbui. 2007. Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. Blood 109, 2310-2313. https://doi.org/10.1182/blood-2006-09-046342
  4. Clark, J. M., F. L. Brancati, and A. M. Diehl. 2003. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 98, 960-967. https://doi.org/10.1111/j.1572-0241.2003.07486.x
  5. Cole, D. R., E. B. Singian, and L. N. Katz. 1954. The long-term prognosis following myocardial infarction, and some factors which affect it. Circulation 9, 321-334. https://doi.org/10.1161/01.CIR.9.3.321
  6. Coller, B. S. 2005. Leukocytosis and ischemic vascular disease morbidity and mortality: Is it time to intervene? Arterioscler. Thromb. Vasc. Biol. 25, 658-670. https://doi.org/10.1161/01.ATV.0000156877.94472.a5
  7. Cushman, M., R. N. Lemaitre, L. H. Kuller, B. J. Psaty, E. M. Macy, A. R. Sharrett, and R. P. Tracy. 1999. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 19, 493-498. https://doi.org/10.1161/01.ATV.19.3.493
  8. Danenberg, H. D., A. J. Szalai, R. V. Swaminathan, L. Peng, Z. Chen, P. Seifert, W. P. Fay, D. I. Simon, and E. R. Edelman. 2003. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation 108, 512-515. https://doi.org/10.1161/01.CIR.0000085568.13915.1E
  9. Faraday, N., L. R. Yanek, D. Vaidya, B. Kral, R. Qayyum, J. E. Herrera-Galeano, T. F. Moy, D. M. Becker, and L. C. Becker. 2009. Leukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery disease. Thromb. Res. 124, 311-317. https://doi.org/10.1016/j.thromres.2008.12.031
  10. Farrera, J. A., A. Jauma, J. M. Ribo, M. A. Peire, P. P. Parellada, S. Roques-Choua, E. Bienvenue, and P. Seta. 1994. The antioxidant role of bile pigments evaluated by chemical tests. Bioorg. Med. Chem. 2, 181-185. https://doi.org/10.1016/S0968-0896(00)82013-1
  11. Ferdinand, K. C. 2006. Coronary artery disease in minority racial and ethnic groups in the United States. Am. J. Cardiol. 97, 12A-19A.
  12. Ghem, C., R. E. Sarmento-Leite, A. S. de Quadros, S. Rossetto, and C. A. Gottschall. 2010. Serum bilirubin concentration in patients with an established coronary artery disease. Int. Heart J. 51, 86-91. https://doi.org/10.1536/ihj.51.86
  13. Gibler, W. B., G. P. Young, J. R. Hedges, L. M. Lewis, M. S. Smith, S. C. Carleton, R. V. Aghababian, R. O. Jorden, E. J. Jr Allison, and E. J. Otten. 1992. Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: serial CK-MB sampling in the emergency department. The Emergency Medicine Cardiac Research Group. Ann. Emerg. Med. 21, 504-512. https://doi.org/10.1016/S0196-0644(05)82515-6
  14. Gordon, D. J., J. L. Probstfield, R. J. Garrison, J. D. Neaton, W. P. Castelli, J. D. Knoke, D. R. Jr Jacobs, S. Bangdiwala, and H. A. Tyroler. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79, 8-15. https://doi.org/10.1161/01.CIR.79.1.8
  15. Hansson, G. K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695. https://doi.org/10.1056/NEJMra043430
  16. Helfand, M., D. I. Buckley, M. Freeman, R. Fu, K. Rogers, C. Fleming, and L. L. Humphrey. 2009. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann. Intern. Med. 151, 496-507. https://doi.org/10.7326/0003-4819-151-7-200910060-00010
  17. Khaleghi, M., L. A. Singletary, V. Kondragunta, K. R. Bailey, S. T. Turner, T. H. Jr. Mosley, and I. J. Kullo. 2009. Haemostatic markers are associated with measures of vascular disease in adults with hypertension. J. Hum. Hypertens. 23, 530-537. https://doi.org/10.1038/jhh.2008.170
  18. Khot, U. N., M. B. Khot, C. T. Bajzer, S. K. Sapp, E. M. Ohman, S. J. Brener, S. G. Ellis, A. M. Lincoff, and E. J. Topol. 2003. Prevalence of conventional risk factors in patients with coronary heart disease. J. A. M. A. 290, 898-904. https://doi.org/10.1001/jama.290.7.898
  19. Lee, S. C., Y. T. Kim, S. M. Moon, K. Y. Hyun, D. S. Kim, and S. C. Choi. 2008. Factors affecting the postoperative outcome in adult cardiac surgery with cardiopulmonary bypass. J. Life Sci. 18, 1493-1498. https://doi.org/10.5352/JLS.2008.18.11.1493
  20. Lip, G. Y. H. and G. D. O. Lowe. 1995. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin. Sci. 89, 205-214.
  21. Margolis, K. L., J. E. Manson, P. Greenland, R. J. Rodabough, P. F. Bray, M. Safford, R. H. Jr Grimm, B. V. Howard, A. R. Assaf, and R. Prentice; Women's Health Initiative Research Group. 2005. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch. Intern. Med. 165, 500-508. https://doi.org/10.1001/archinte.165.5.500
  22. Medeiros, L. J., D. Schotte, and B. Gerson. 1987. Reliability and significance of increased creatine kinase MB isoenzyme in the serum of uremic patients. Am. J. Clin. Pathol. 87, 103-108.
  23. Michos, E. D., K. Nasir, J. A. Rumberger, C. Vasamreddy, J. B. Braunstein, M. J. Budoff, and R. S. Blumenthal. 2005. Relation of family history of premature coronary heart disease and metabolic risk factors to risk of coronary arterial calcium in asymptomatic subjects. Am. J. Cardiol. 95, 655-657. https://doi.org/10.1016/j.amjcard.2004.10.045
  24. Murphy, A. J., K. J. Woollard, A. Hoang, N. Mukhamedova, R. A. Stirzaker, S. P. McCormick, A. T. Remaley, D. Sviridov, and J. Chin-Dusting. 2008. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28, 2071-2077. https://doi.org/10.1161/ATVBAHA.108.168690
  25. Neuzil, J. and R. Stocker. 1994. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269, 16712-16719.
  26. Paul, A., K. W. Ko, L. Li, V. Yechoor, M. A. McCrory, A. J. Szalai, and L. Chan. 2004. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 109, 647-655. https://doi.org/10.1161/01.CIR.0000114526.50618.24
  27. Pradhan, A. D., A. Z. LaCroix, R. D. Langer, M. Trevisan, C. E. Lewis, J. A. Hsia, A. Oberman, J. M. Kotchen, and P. M. Ridker. 2004. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women. Circulation 110, 292-300. https://doi.org/10.1161/01.CIR.0000134965.73212.A6
  28. Prentice, R. L., T. P. Szatrowski, T. Fujikura, H. Kato, M. W. Mason, and H. H. Hamilton. 1982. Leukocyte counts and coronary heart disease in a Japanese cohort. Am. J. Epidemiol. 116, 496-509.
  29. Rader, D. J. 2006. Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest. 116, 3090-3100. https://doi.org/10.1172/JCI30163
  30. Rye, K. A. and P. J. Barter. 2008. Antiinflammatory actions of HDL: a new insight. Arterioscler. Thromb. Vasc. Biol. 28, 1890-1891. https://doi.org/10.1161/ATVBAHA.108.173575
  31. Saely, C. H., S. Aczel, T. Marte, P. Langer, G. Hoefle, and H. Drexel. 2005. The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. J. Clin. Endocrinol. Metab. 90, 5698-5703. https://doi.org/10.1210/jc.2005-0799
  32. Saely, C. H., A. Vonbank, P. Rein, M. Woess, S. Beer, S. Aczel, V. Jankovic, C. Boehnel, L. Risch, and H. Drexel. 2008. Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis. Clin. Chim. Acta. 397, 82-86. https://doi.org/10.1016/j.cca.2008.07.024
  33. Schindhelm, R. K., J. M. Dekker, G. Nijpels, C. D. Stehouwer, L. M. Bouter, R. J. Heine, and M. Diamant. 2007. Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabet. Med. 24, 430-435. https://doi.org/10.1111/j.1464-5491.2007.02100.x
  34. Szmitko, P. E., C. H. Wang, and R. D. Weisel. 2003. New markers of inflammation and endothelial cell activation: Part I. Circulation 108, 1917-1923. https://doi.org/10.1161/01.CIR.0000089190.95415.9F
  35. Tataru, M. C., J. Heinrich, R. Junker, H. Schulte, A. von Eckardstein, G. Assmann, and E. Koehler. 1999. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur. Heart J. 20, 1493-1502. https://doi.org/10.1053/euhj.1999.1519
  36. von Haehling, S., J. C. Schefold, E. Jankowska, W. Doehner, J. Springer, K. Strohschein, S. Genth-Zotz, H. D. Volk, P. Poole-Wilson, and S. D. Anker. 2009. Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure. P. Lo. S. One. 4, e6411-e6417. https://doi.org/10.1371/journal.pone.0006411
  37. Wannamethee, S. G., P. H. Whincup, A. G. Shaper, A. Rumley, L. Lennon, and G. D. Lowe. 2009. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J. Thromb. Haemost. 7, 1605-1611. https://doi.org/10.1111/j.1538-7836.2009.03574.x
  38. Wilson, P. W., R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel. 1998. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837-1847. https://doi.org/10.1161/01.CIR.97.18.1837
  39. Zairis, M. N., E. N. Adamopoulou, S. J. Manousakis, A. G. Lyras, G. P. Bibis, O. S. Ampartzidou, C. S. Apostolatos, F. A. Anastassiadis, J. J. Hatzisavvas, S. K. Argyrakis, and S. G. Foussas. 2007. Biomarkers of Inflammation and Outcome in Acute Coronary Syndromes (BIAS) Investigators. The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes. Atherosclerosis 194, 397-402. https://doi.org/10.1016/j.atherosclerosis.2006.08.008